2022
DOI: 10.1039/d1cp04736a
|View full text |Cite
|
Sign up to set email alerts
|

A multiple-step in silico screening protocol to identify allosteric inhibitors of Spike–hACE2 binding

Abstract: While the COVID-19 pandemic keeps deteriorating, the effective medicines target the life cycle of SARS-CoV-2 are still under development. With more highly infective and dangerous variants of the coronavirus emerged,...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 43 publications
(40 reference statements)
0
2
0
Order By: Relevance
“…18 Taking the calculated results and visual analysis, 4 compounds (3719810, 17980455, 10199019, and 17823867) were identified with reasonable binding poses in two targets, and their molecular docking scores are shown in Table 1. The docking scores of the 4 compounds were from À7.025 to À10.156 lower than À7.0 kcal mol À1 , 72 which indicated that all molecules were able to effectively bind in hNET and hDAT, and reflected to some extent their abilities to combine with targets. Their docking poses and the conformations of the 4 compounds are illustrated in the ESI, † Fig.…”
Section: Compound Selection Based On Homology Modeling and Molecular ...mentioning
confidence: 93%
“…18 Taking the calculated results and visual analysis, 4 compounds (3719810, 17980455, 10199019, and 17823867) were identified with reasonable binding poses in two targets, and their molecular docking scores are shown in Table 1. The docking scores of the 4 compounds were from À7.025 to À10.156 lower than À7.0 kcal mol À1 , 72 which indicated that all molecules were able to effectively bind in hNET and hDAT, and reflected to some extent their abilities to combine with targets. Their docking poses and the conformations of the 4 compounds are illustrated in the ESI, † Fig.…”
Section: Compound Selection Based On Homology Modeling and Molecular ...mentioning
confidence: 93%
“…A library of drug-like molecules and a smaller library of validated allosteric modulators were compiled for screening against site A (Figure 4) and site B (Figure 5). Library 1 consisted of 200 drug-like compounds from ZINC database that showed SARS-CoV-2 in vitro activity [57]. For this library, we used the compounds with the highest affinity for the two druggable sites on the RBD [57].…”
Section: Simulations Of the Sars-cov-2 Spike Trimers And Analysis Of ...mentioning
confidence: 99%
“…Utilizing screening data from the SARS-CoV-2 cytopathic effect reduction assay, two iterative rounds of virtual screening of small molecules were then performed against SARS-CoV-2, resulting in the identification of ACE2 allosteric inhibitors [56]. A large-scale computational study presented a multiple-step in silico screening protocol to identify allosteric inhibitors of S-ACE2 binding in which a compound library containing 77,448 antiviral compounds was screened using molecular docking and binding affinity calculations [57]. The use of screening of library of organic dyes and related drug-like compounds led to the identification of several small-molecule compounds, showing promising broad-spectrum inhibition of the S-ACE2 interactions acting as blockers of viral attachment for SARS-CoV-2 [58].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the decrease in deaths after the beginning of the vaccination programs, the continuous mutation of the virus has reduced the protective efficacy of the available vaccines and monoclonal antibodies (mAbs) ( Harvey et al, 2021 ; McCarthy et al, 2021 ; Cox et al, 2023 ). Moreover, only a few drugs have shown some degree of efficacy in treating the infection and its complications, with some of them being reported to present severe side effects, resistance, and rebound phenomena ( Kobryn et al, 2021 ; Anderson et al, 2022 ; Charness et al, 2022 ; Zhai et al, 2022 ; Iketani et al, 2023 ; Moghadasi et al, 2023 ). Thus, intensive research has been carried out to find efficient therapies for the treatment and prevention of the current and future coronavirus outbreaks.…”
Section: Introductionmentioning
confidence: 99%